Menu Search
Equities

Waters Corp

WAT:NYQ

Waters Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)364.48
  • Today's Change6.70 / 1.87%
  • Shares traded146.19k
  • 1 Year change+32.71%
  • Beta0.9814
Data delayed at least 15 minutes, as of Nov 21 2024 17:11 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Waters Corp's net income fell -9.26% from 707.76m to 642.23m despite flat revenues.
Gross margin59.73%
Net profit margin21.43%
Operating margin27.48%
Return on assets13.82%
Return on equity49.64%
Return on investment16.72%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Waters Corp fell by 85.45m. Cash Flow from Financing totalled 754.95m or 25.54% of revenues. In addition the company generated 602.81m in cash from operations while cash used for investing totalled 1.44bn.
Cash flow per share13.71
Price/Cash flow per share26.07
Book value per share27.00
Tangible book value per share-4.98
More ▼

Balance sheet in USDView more

Waters Corp has a Debt to Total Capital ratio of 53.25%, a lower figure than the previous year's 271.14%.
Current ratio2.02
Quick ratio1.38
Total debt/total equity1.14
Total debt/total capital0.5325
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items dropped -7.63%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
EPS growth(5 years)7.16
EPS (TTM) vs
TTM 1 year ago		-4.70
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.